key: cord-352781-aqh9zxgh
authors: El Homsi, Maria; Chung, Michael; Bernheim, Adam; Jacobi, Adam; King, Michael J.; Lewis, Sara; Taouli, Bachir
title: Review of Chest CT Manifestations of COVID-19 Infection
date: 2020-06-07
journal: Eur J Radiol Open
DOI: 10.1016/j.ejro.2020.100239
sha: 
doc_id: 352781
cord_uid: aqh9zxgh

Coronavirus disease-19 (COVID-19) is a viral pandemic that started in China and has rapidly expanded worldwide. Typical clinical manifestations include fever, cough and dyspnea after an incubation period of 2-14 days. The diagnosis is based on RT-PCR test through a nasopharyngeal swab. Because of the pulmonary tropism of the virus, pneumonia is often encountered in symptomatic patients. Here, we review the pertinent clinical findings and the current published data describing chest CT findings in COVID-19 pneumonia, the diagnostic performance of CT for diagnosis, including differential diagnosis, as well the evolving role of imaging in this disease.

Serum immunoglobulins (IgM and IgG) can be used to diagnose recent infection to COVID-19 [24] . For example, a study demonstrated that the positive detection rate is increased (98.6%) when combining IgM assay with RT-PCR compared to RT-PCR alone (51.9%) [25] .

A total of 30 original papers published in English totaling over 4000 patients were reviewed [23, . Reviews and case reports were excluded. Most reviewed papers originate from China [23, 26-35, 37-40, 44-48, 50-53] and the remainder from Japan [43, 49] , Korea [41] and Italy [42, 54] . Three papers were in collaboration between Chinese and US institutions [27, 29, 45] .

Chest radiography (CXR) findings in patients with COVID-19 have been described in small case series [41, 46] . CXR is negative in 40%-66.7% of cases despite positive findings on chest CT ( Fig.1) [41, 46] . The most common radiographic finding is opacification, often with a peripheral and lower lung distribution [41, 46] (Fig.2) . Thus, CXR is not recommended for routine diagnosis of COVID-19, but may be helpful for follow-up.

A low dose, chest CT without intravenous contrast is generally used for evaluation [55] .

Typically, COVID-19 pneumonia presents with bilateral peripheral patchy ground-glass opacities (GGO) with or without consolidation [40, 44, 56] (Fig. 2, 3) . GGOs may have a rounded morphology [27, 29, 33, 39, 42] in up to 54% of the cases (Fig. 4) . Superimposed interlobular septal thickening can also be present, resulting in a crazy-paving pattern (Fig.2) . Vascular enlargement, air bronchograms, and a halo sign have also been described (Fig.2) . The GGOs and consolidative lesions are larger than1cm in 91% of cases [40] . The lower lobes and posterior portions are more frequently involved [39] . Mediastinal and hilar lymphadenopathy, pleural effusions or thickening, discrete pulmonary nodules, and pulmonary cavitation have been rarely described in the Chinese series [27, 29, 40 ]. An Italian study described lymphadenopathy in up to 58% of cases [42] . Table 1 shows the prevalence of various imaging findings on chest CT at initial presentation.

A Japanese study described that asymptomatic patients tend to have more GGO (80%) and less consolidation (20%) compared with symptomatic patients (63% and 38%) [43] . CXR and chest CT can be negative in up to 17.9% of patients, especially in early and/or non severe disease [6] . In mild cases, CT findings consist more frequently of GGO alone (65%), followed by GGO with consolidation (44%) [40] . Severe cases with a clinical acute respiratory distress syndrome (ARDS) picture present with widespread dense consolidative opacification on CT (see below).

Several studies categorized COVID-19 CT findings into several stages based on time since the onset of symptoms [10, 26, 27, 33, 39] . These were classified into 4 main successive stages: early, intermediate and late [27] and a fourth resorptive stage [50] .

 Early stage (≤2 days): More than half of the patients have negative chest CT (56%). The remaining patients have predominantly GGO (44%) and consolidation (17%). Imaging findings when present were often unilateral [27] . Similar findings were described in another study [39] , which demonstrated that in early disease 16.1% of cases present with a solitary lesion seen in 70% of cases in the right lower lobe.

 Intermediate stage (3-5 days): As the disease progresses, more GGO (88%) and consolidation (55%) are noted bilaterally (76%) and with a peripheral lung distribution (64%).

Only 9% of patients have negative chest CT [27] . 88% and 60% of patients have GGO and consolidation, respectively. The imaging findings are bilateral in 88% and peripheral-predominant in 72% of cases [27] .

 Absorption stage/fourth stage (>14 days): 65% and 75% of patients have GGO and consolidation, respectively. The imaging findings are bilateral in 88% and peripheralpredominant in 72% of cases [50] .

When patients improve, the lung disease evolves and organizes, and fibrous bands may appear [35, 38, 47, 57] . A "reverse-halo sign" is occasionally observed and can be an indication of organizing pneumonia [46, 58] . In severe cases, the consolidation and GGO increase and involve all five lung lobes, resulting in a dense consolidative appearance and characterized by diffuse alveolar damage, usually with a poor prognosis [47] (Fig.5. )

It has been suggested that imaging can help predict severity of COVID-19 disease. For example, a study showed that a severity score based on CXR at initial presentation in nonelderly patients (21-50y) predicts outcome (hospital admission and intubation) [59] . Another study suggested that severe/fatal cases were more likely to have more extensive and diffuse disease with more frequent architectural distortion and bronchiectasis compared to mild/common cases [37] . However, more data is needed particularly in comparison with blood tests, such as cytokine levels.

Oncology patients: A retrospective study in 28 oncologic patients showed similar findings of GGO (75%) and patchy consolidation (46.3%). The presence of the latter at admission was associated with worse outcome [60] .

Pediatric and pregnant patients: Few studies have described chest CT findings in children [61] [62] [63] [64] who tend to have milder findings. The largest study included 13 patients [64] , 20% of whom had normal chest CT, 60% had GGO, and 50% had consolidation with a surrounding halo (which was considered a typical finding in this population). Bilateral disease was observed in 50% of cases. Co-infection with another pathogen was identified in 2%-40% of the cases [63, 64] . Another study [65] found that pregnant women have more consolidation (up to 56%) as compared with the non-pregnant population (21%). Pregnant woman also manifested with bilateral and peripheral-predominant GGO. Pleural effusions were more commonly encountered in pregnant than in non-pregnant women, up to 38% versus 7%.

Elderly population: Older patients (>60y) have similar (classic) chest CT findings [53] . However, they tend to have more areas of lung involvement with more lobes affected and more pleural thickening [53] . Similar findings were obtained in another study [32] , where patients older than 50 years had more extensive disease with more consolidation as compared with patients younger than 50. They tended to have more architectural distortion, bronchiectasis, mediastinal and hilar lymphadenopathy and pleural effusions and worse outcomes than younger patients [37] .

COVID-19 and pulmonary embolism: An increased incidence of acute pulmonary embolism in hospitalized COVID-19 patients has been reported [66] . Out of 25 patients, 40% had an acute pulmonary embolism and it was associated with elevated D-dimer (up to 11.07 ug/mL). COVID-19 can be associated with pulmonary embolism especially when D-dimer is elevated (Fig. 6) , and preventive anticoagulation has been recommended in hospitalized patients [67] . [36, 68] . A study performed by Bai et al found that 6 of 7 radiologists had high specificity (93-100%) and moderate sensitivity (67-93%) in distinguishing COVID-19 pneumonia from other viral pneumonias, although there was variability in radiologist performance [45] . Compared to viral pneumonia, COVID-19 tends to have a more peripheral distribution, greater GGO, increased vascular enlargement and a "reverse-halo sign". Zhao et al also demonstrated that COVID-19 had more frequent bilateral GGOs compared to non-COVID-19 viral infections [11] . Key findings less frequent in COVID-19 pneumonia compared to non-COVID pneumonia included air bronchograms, centrilobular nodules, tree-in-bud opacities, bronchial wall thickening and a reticular pattern [28, 36] . Other coronavirus organisms with genetic resemblance to COVID-19 can produce similarly devastating pulmonary syndromes, including SARS (9.4% mortality rate) and MERS (34.4% mortality rate) [69, 70] . While there have been no documented cases of SARS since 2003, MERS cases are still reported sporadically. All three of these infections cause peripheral multifocal airspace opacities (GGO and/or consolidation), without pneumothorax, cavitation or lymphadenopathy. Differences in the imaging appearances have been reported, as SARS tends to be unilateral and focal in distribution (50%) and MERS patients can develop pleural effusion (33%) [71, 72] . Both SARS and MERS are associated with constriction of the pulmonary vasculature, whereas enlargement of the vasculature has been reported in COVID-19 [73] .

Pulmonary fibrosis was reported as a late manifestation in MERS, but not in SARS. The longterm sequelae of COVID-19 remain to be determined; however, early publications indicate a fibrotic phase characterized by reticulation, interlobular septal thickening and traction bronchiectasis [47, 69] .

Finally, a variety of other noninfectious pulmonary diseases can produce imaging findings on CT that may overlap with COVID-19 pneumonia, including pulmonary edema, ARDS, organizing pneumonia, prior treatment (i.e. drug toxicity or radiation pneumonitis/fibrosis), pulmonary infarction, alveolar hemorrhage, and interstitial lung diseases [74] . Both ARDS and bacterial superinfection can complicate COVID-19 pneumonia. While there is an abundance of literature being published at a rapid rate, results of these studies must be scrutinized and interpreted with caution as a variety of sources of bias may produce artificially high performance characteristics of CT and certain imaging findings for COVID-19 pneumonia [74] . Ultimately, given the variable and non-specific nature of the imaging findings in COVID-19, integration of clinical history, laboratory tests, in addition to quantitative approaches including machine learning or artificial intelligence (AI, see below), are needed for accurate assessment.

Several studies compared the accuracy of chest CT against RT-PCR [23, 31, 42, 44, 48] .

Abnormal chest CT findings can be present despite a negative RT-PCT with a sensitivity ranging between 72%-97% [23, 42, 44, 45] . However, according to Raptis et al this high sensitivity can be explained by a selection bias of the studied population and low threshold for positive disease on chest CT [75] . Using RT-PCR as a reference, specificity of chest CT ranges between 25%-56% and accuracy between 68%-72% [42, 44] . The positive predictive value and accuracy of chest CT were higher in patients older than 60 years. 42% of cases had improvement of imaging findings before negative conversion of RT-PCR [44] . The positive rate of RT-PCR was 32%-93% [22, 23, 44] . This can be explained by the fact that RT-PCR was obtained through throat swabs which have low positive rates [36, 52] as viral pneumonia does not usually produce purulent sputum [48] .

With the rapid evolution of this outbreak, the global community of radiologists has convened to construct guidelines and position statements regarding the appropriate use of imaging during this pandemic. Early in the outbreak, hospitals in China were using chest CT in many suspected patients, as well as to follow-up the progression of lung disease. In the US, the Centers for Disease Control and Prevention (CDC), the American College of Radiology (ACR), the Society of Thoracic Radiology (STR), and the American Society of Emergency Radiology (ASER) issued their position statements recommending against the use of CT for widespread screening and diagnosis of COVID-19, instead reserving CT for those cases with clinical suspicion for complications like abscess or empyema [76] [77] [78] . This was largely spurred by the early research on Chinese patients which showed that imaging, specifically CT, has a wide range in sensitivity for detecting COVID-19 pneumonia [27, 44] . In addition, the CT imaging features of COVID-19 J o u r n a l P r e -p r o o f Page 13 of 37 are sometimes nonspecific and can overlap with other infections as discussed above. The positive predictive value of CT is low in locations where COVID-19 prevalence is low [79] .

The multinational consensus statement of the Fleischner society [80] recommended chest CT for patients with moderate to severe symptoms or with mild disease with associated comorbidities or with worsening respiratory symptoms. The European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI) outlined their recommendations in a consensus document, stating that chest CT should not be performed as a screening tool in patients with "mild or no symptoms" [81] . However, they add on that chest CT may play a useful role in patients with milder symptoms who have co-morbidities (e.g. diabetes, obesity, chronic respiratory disease, etc.). In their statement, they also note that with further research, information gained from a baseline CT in COVID-19 patients may play an important role in predicting who will have poor outcomes or need ventilation.

With the spread of COVID-19 globally and the increasing number of CTs performed in patients under investigation (PUIs), there have been frequent questions in the radiology community regarding the optimal way to report CT findings potentially attributable to COVID-19 pneumonia.

A national expert panel of thoracic radiologists gathered to produce a consensus statement on this topic, subsequently endorsed by the Radiological Society of North America (RSNA), the STR, and the ACR [82] .

Chest CT findings were classified for COVID-19 pneumonia into four groups: typical appearance, indeterminate appearance, atypical appearance, and negative for pneumonia. Standardized language templates are provided in [82] with the goal of decreasing reporting variability and increasing clarity by using consistent language. The question of whether to include terminology such as "coronavirus" or "COVID-19" in reports remains an area of debate. The authors acknowledge that for patients with unexpected findings that could be attributable to COVID-19, the matter is complex and consultation with local clinical colleagues is needed to establish an approach. The term "viral pneumonia" is considered a reasonable alternative.

Given the variable sensitivity in RT-PCR for the diagnosis of early COVID-19 and the overlap in the imaging appearances with other pulmonary diseases, AI approaches have been applied in an effort to improve the diagnostic accuracy of CT. In a recent retrospective multicenter study of 4,356 chest CTs from 3,322 patients, a deep learning model detection neural network (COVNet) in an independent test set demonstrated excellent per-exam AUC, sensitivity and specificity of 0.96, 90% and 96%, respectively for detecting COVID-19 compared to CAP and other nonpneumonias [83] . Other studies using deep learning approaches have found similar results with reported AUCs up to 0.996 [84, 85] and accuracy up to 86.7% [86] for the classification of COVID-19 from non-COVID-19 pulmonary infection. A recently published algorithm integrating chest CT and clinical history in patients presenting early in the course of the disease reached an AUC of 0.92 and had higher sensitivity (84.3%) when compared to a senior thoracic radiologist (74.6%) and a thoracic radiology fellow (56%). The algorithm was able to identify 68% of cases presenting with positive RT-PCR but normal chest CT. This method may have a role for a quick diagnosis of COVID-19 pneumonia with CT [87] . More work in terms of performance and clinical implementation/acceptance is needed.

Page 15 of 37 COVID-19 is a new rapidly spreading pandemic. It has typical CT findings with GGOs and consolidation often with a peripheral and lower lung distribution. In early disease, imaging findings can be absent; therefore, CT chest cannot be used as a screening method, and RT-PCR remains the reference diagnostic test. AI may play a role in the rapid diagnosis of COVID-19, but more data is needed to assess its added value.

There is no conflict of interest associated with this publication and there has been no financial support for this work posterior chest X-ray shows ill-defined opacities in the lateral aspect of the right lung (arrows).

(b) Axial noncontrast chest CT image shows ground-glass opacities with a peripheral distribution in both upper lobes (arrows). There is superimposed interlobular septal thickening with visible intralobular lines in the ground-glass opacity (crazy paving pattern). (c)

Reconstructed coronal chest CT image shows corresponding multifocal bilateral ground-glass opacities with a peripheral distribution (arrows). 

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Presenting Characteristics, Comorbidities, and Outcomes Among

Patients Hospitalized With COVID-19 in the

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention

Clinical features of patients infected with 2019 novel coronavirus in

Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive

A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias

Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes

Gastrointestinal Symptoms and COVID-19: Case-Control Study from the United States

Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study

Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Hematological findings and complications of COVID-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-Specimens

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR

A serological assay to detect SARS-CoV-2 seroconversion in humans

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Relationship to Duration of Infection

Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Imaging Features of Coronavirus disease 2019 (COVID-19): Evaluation on Thin-Section CT

COVID-19): Role of Chest CT in Diagnosis and Management

Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia

Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area

Chest CT Findings in Patients with Corona Virus Disease 2019 and its Relationship with Clinical Features

Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2

The role of imaging in 2019 novel coronavirus pneumonia (COVID-19)

Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study

Coronavirus disease 2019: initial chest CT findings

CT Features of Coronavirus Disease

Pneumonia in 62 Patients in Wuhan, China

Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia

Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea

Chest CT Features of COVID-19 in

Chest CT Findings in Cases from the Cruise Ship "Diamond Princess

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT

Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in

Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing

Diagnostic performance of chest CT to differentiate COVID-19 pneumonia in non-high-epidemic area in Japan

Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city

Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China

COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review

Recommendation of low-dose CT in the detection and management of COVID-2019

A Scoping review

Evolution of Computed Tomography Manifestations in Five Patients Who Recovered from Coronavirus Disease 2019 (COVID-19) Pneumonia

Chest Imaging Appearance of COVID-19 Infection

Clinical and Chest Radiography Features Determine Patient Outcomes In Young and Middle Age Adults with COVID-19

Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan

Chest computed tomography in children with COVID-19 respiratory infection

High-Resolution Computed Tomography Manifestations of 5

Pediatric Patients With 2019 Novel Coronavirus

Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children

Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults

Deep Convolutional Neural Network-aided Detection of Portal Hypertension in Patients With Cirrhosis

Findings of acute pulmonary embolism in COVID-19 patients, The Lancet Infectious Diseases

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

Coronavirus Disease 2019 (COVID-19): A Perspective from China

Outbreak of novel coronavirus (COVID-19): What is the role of radiologists?

A Novel Coronavirus Emerging in China -Key Questions for Impact Assessment

Middle East Respiratory Syndrome Coronavirus: What Does a Radiologist Need to Know?

Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome

2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation

COVID-19): A Critical Review of the Literature to Date

COVID-19): A Critical Review of the Literature to Date

ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection

Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection

ASER COVID-19 Task Force: FAQs. ASER website

STR COVID-19 Position Statement. STR website

s. six, A role for CT in COVID-19? What data really tell us so far

The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society

European Society of, I. the European Society of Thoracic, COVID-19 patients and the radiology department -advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI)

Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA

Rapid AI Development Cycle for the Coronavirus (COVID-19) Pandemic: Initial Results for Automated Detection & Patient Monitoring using Deep Learning CT Image Analysis

Deep learning Enables Accurate Diagnosis of Novel Coronavirus (COVID-19) with CT images

Deep Learning System to Screen Coronavirus Disease

Artificial intelligence-enabled rapid diagnosis of patients with COVID-19

More than 2 lobes affected 62

Uncommon Findings Centrilobular nodules 15

Tree-in-bud nodularity 9